Henry Ford Health

We're proud to share that our Information Technology (IT) Business Systems team has received the prestigious Oracle PeopleSoft Innovator Award! 💡 This distinguished recognition celebrates the team's innovative transformation initiatives aimed at enhancing user experience and leveraging analytics, accomplished in close collaboration with Human Resources, Finance and Supply Chain. Our IT team’s notable achievements include: 🔹Launching mobile-accessible benefit enrollment 🔹Optimizing the onboarding process 🔹Creating data-driven insight dashboards These initiatives have simplified and improved HR processes for all our team members, making it easier to enroll in benefits and complete onboarding with efficiency and ease. Congratulations to the entire team on this well-deserved honor!

A recent study published in JAMA reveals the impactful results of the "Zero Suicide (ZS) Model," implemented in our behavioral health clinics and five Kaiser Permanente health systems. Developed by our Behavioral Health Services team in 2001, the ZS Model focuses on patient screening, safety planning, mental health counseling, and follow-up care to identify and address suicide risk. Over an 8-year period, our researchers - along with Kaiser Permanente - examined implementation of the ZS Model in both primary care and behavioral health settings. The study revealed that the model helped reduce suicide rates by up to 25% among at-risk patients. “‘Zero Suicide’ may seem like an impossible goal, but we believe we should strive every day to try to prevent suicide among our patients,” said Dr. Brian Ahmedani, lead author of the study and director of research for our Behavioral Health Services. “This is the best evidence yet that we have the tools to recognize those in distress, intervene, and help them change course.” Read more of the Zero Suicide Model Implementation Study findings in JAMA.

On May 16, our experts will share promising clinical trial data, key controversies in bladder cancer management, and evidence-based clinical and technical advances at our multidisciplinary bladder cancer symposium. Through leading-edge lectures, case discussions, and interactive Q&A sessions, participants will gain valuable knowledge to apply principles of bladder cancer management to complex cases. AMA PRA credits available. Register at the event details below.

The Annual Medallion Gala celebrated our doctors, nurses and team members who make a lasting impact at Henry Ford Macomb Hospital! At the celebration, retired Henry Ford Macomb Hospital president Barbara Rossmann was presented with the inaugural Barbara Rossmann Community Leadership Award – created to honor recipients for their remarkable dedication, compassion and leadership. Congratulations to our 2025 Medallion Awardees! 🏆 🔹Dr. Raed Alnajjar, Cardiothoracic Surgeon 🔹Kristin Baffo, Emergency Department Director of Nursing 🔹Angela VanHazenbrouck, Interventional Radiology Technologist

The Women's Heart Program recently convened team members and providers from outside our system for an in-depth educational session, reinforcing the critical importance of women’s heart health. Our six Women's Heart Clinic medical directors shared expertise on: ❤️ Coronary artery disease & microvascular disease ❤️ Postural Orthostatic Tachycardia Syndrome (POTS) ❤️ Cardio-obstetrics & postpartum care ❤️ Tailoring diagnosis & treatment for women Heart disease remains the leading cause of death in women and education is a vital step in closing the gap. Grateful for our incredible team for leading the way in women’s cardiovascular care!

Happy Opening Day, Detroit! 💙⚾ Our team members stepped up to the plate in their best spirit wear to cheer on your Detroit Tigers — let’s play ball! To join our winning team, email IAmHenryTalent@hfhs.org.

WORLD-FIRST: Our team at Henry Ford Macomb Hospital, led by cardiothoracic surgeon Dr. RAED ALNAJJAR, has made history as the first globally to use the MONARCH robotic bronchoscopy platform with MONARCH QUEST - an AI-powered navigation system designed to improve precision in targeting lung nodules. With real-time 3D imaging, this next-generation technology aids clinicians in reaching early-stage lesions in the periphery of the lung that traditional bronchoscopy struggles to access. Congratulations to our team on this groundbreaking advancement in lung cancer detection! 👏

We’re proud to announce that the American Medical Group Association (AMGA) has honored us with the 2025 Acclaim Award! This prestigious award recognizes healthcare organizations that provide safe, effective, patient-centered, efficient and equitable care to the communities they serve. Through surveys and data analysis, we’ve improved patient care, identified populations with an increased need for outreach and education, reduced healthcare costs and introduced new programs to reduce physician burnout. “Every day, our physicians are deeply focused on building meaningful relationships with our patients, providing them with the highest quality care and improving their health and wellness," said Dr. Jerome Finkel, our SVP & Chief Primary Health Officer. "Our mission and core purpose is to make the impossible possible, and we are so privileged to have the opportunity to impact—and improve—the healthcare landscape in Michigan and beyond.”

A winning combination! 🏀👨🍳 Last week, we partnered with the Detroit Pistons for the Ready, Set, Cook competition as part of Pistons FIT. Students from our SandCastles Grief Support Program collaborated with Pistons legend Grant Long and NBA champion Lindsey Hunter to create delicious, healthy meals for a panel of judges. It was a fun and flavorful victory for everyone involved! 🍽️

Groundbreaking research from our pancreatic cancer center revealed race-associated molecular differences in tumors that could impact how patients respond to immunotherapy. 🧬 In the study recently published by the American Association for Cancer Research, our researchers found that Black patients showed a higher prevalence of PD-L1 overexpression, a marker often linked with aggressive cancer behavior and a key target for immunotherapy treatments. Patients in the study also showed higher frequencies of of TP53 mutations and KRASG12R mutations that affect how quickly cancer grows and the body's ability to fight cancer. “This finding strongly supports that in clinical trials across the country, we need to enroll patients from different racial groups to reflect the racial makeup in the U.S. and to more accurately represent tumor molecular changes,” shared our lead researcher Dr. Ling Huang. Find the full study in the American Association for Cancer Research.